Coldstream Capital Management Inc Haemonetics Corp Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 838 shares of HAE stock, worth $52,366. This represents 0.0% of its overall portfolio holdings.
Number of Shares
838Holding current value
$52,366% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
345Shares Held
52.4MCall Options Held
517KPut Options Held
348K-
Black Rock Inc. New York, NY5.96MShares$372 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$319 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$272 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$164 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$137 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.21B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...